Cezard, Adeline
Brea-Diakite, Déborah
Vasseur, Virginie
Wacquiez, Alan https://orcid.org/0000-0001-5266-5328
Gonzalez, Loic https://orcid.org/0000-0002-5708-3332
Le Goffic, Ronan
Da Costa, Bruno
Tinard, Ambre https://orcid.org/0009-0006-4860-1448
Fouquenet, Delphine https://orcid.org/0009-0005-4179-7997
Heumel, Séverine
Machelart, Arnaud
Hoffmann, Eik https://orcid.org/0000-0003-4224-1091
Brodin, Priscille https://orcid.org/0000-0003-0991-7344
Trottein, François
Mathieu, Cyrille https://orcid.org/0000-0002-6682-2029
Canus, Lola
Jacolin, Florentine
Vidalain, Pierre-Olivier
Perrin-Cocon, Laure https://orcid.org/0000-0003-0501-6733
Lotteau, Vincent
Burlaud-Gaillard, Julien
Tertigas, Dominique
Surette, Michael G
Legras, Antoine
Sizaret, Damien
Baranek, Thomas https://orcid.org/0000-0002-5651-0937
Paget, Christophe https://orcid.org/0000-0002-5374-5407
Guillon, Antoine
Si-Tahar, Mustapha https://orcid.org/0000-0002-5792-7742
Funding for this research was provided by:
Region Centre Val de Loire (FLU-MET 2018-00124196)
FEDER (EuroFERI)
Agence Nationale de la Recherche (ANR-21-CE18-0061)
Agence Nationale de la Recherche (ANR-22-ASTR-0021)
Institut National de la Santé et de la Recherche Médicale (Annual recurrent budget)
Tours university (Annual recurrent budget)
Article History
Received: 17 January 2025
Revised: 31 December 2025
Accepted: 15 January 2026
First Online: 16 February 2026
Disclosure and competing interests statement
: MS-T and AG declared the deposit of a patent application related to the anti-influenza activity of cis -aconitate (reference: WO 2024126742).